Yahoo
NasdaqCM - Delayed Quote USD

Profusa, Inc. (PFSA)

5.46 -2.11 (-27.87%)
At close: August 21 at 4:00:00 PM EDT
5.47 +0.01 (+0.11%)
After hours: August 21 at 7:59:58 PM EDT
Chart Range Bar
Loading chart for PFSA
  • Previous Close 7.57
  • Open 6.65
  • Bid 5.63 x 100
  • Ask 6.90 x 100
  • Day's Range 5.28 - 7.52
  • 52 Week Range 3.22 - 5,190.00
  • Volume 616,790
  • Avg. Volume 1,060,196
  • Market Cap (intraday) 1.384M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1,117.91
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

profusa.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PFSA
97.23%
S&P 500 (^GSPC)
12.11%

1-Year Return

PFSA
99.38%
S&P 500 (^GSPC)
20.47%

3-Year Return

PFSA
99.93%
S&P 500 (^GSPC)
74.43%

5-Year Return

PFSA
99.93%
S&P 500 (^GSPC)
72.78%

Statistics

View More

Valuation Measures

Annual
As of 8/20/2026
  • Market Cap

    1.92M

  • Enterprise Value

    14.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -725.26%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -42.97M

  • Diluted EPS (ttm)

    -1,117.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    719k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -19.32M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

5.46 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: